Skip to main content

Table 1 Baseline characteristics between critically ill patients without CA and with CA

From: Triglyceride-glucose index is associated with the occurrence and prognosis of cardiac arrest: a multicenter retrospective observational study

 

All critically ill patients

(n = 24,689)

Patients without CA (n = 23,668)

Patients with CA (n = 1021)

P-value

Demographic data

    

Age (years)

65(54–76)

65(54–76)

64(55–73)

0.078

Male (n (%))

14,313(58.0)

13,665(57.7)

648(63.5)

0.004

BMI

28.2(24.2–33.5)

28.2(24.1–33.5)

29.0(25.0–34.0)

<0.001

Vital signs

    

HR (/min)

79(67.2–92.0)

79(68–92)

79(65–93)

0.739

SBP (mmHg)

124(108–141)

124(108–141)

115(100–135)

<0.001

DBP (mmHg)

68(58–78)

68(58–78)

64(55–75)

0.006

Temperature (℃)

36.8(36.5–37.1)

36.8(36.5–37.1)

36.6(34.6–37.1)

<0.001

SpO2 (%)

97(95–99)

97(95–99)

99(95–100)

0.002

Comorbidities

    

MI (n (%))

4515(18.3)

4266(18.0)

249(24.4)

<0.001

AF (n (%))

2165(8.8)

2063(8.7)

102(10.0)

0.088

CHF (n (%))

2078(8.4)

1970(8.3)

108(10.6)

0.007

CKD (n (%))

1009(4.1)

951(4.0)

58(5.7)

0.005

ARF (n (%))

2173(8.8)

1940(8.2)

233(22.8)

<0.001

Diabetes (n (%))

2777(11.2)

2651(11.2)

126(12.3)

0.265

Hypertension (n (%))

4747(19.2)

4614(19.5)

133(13.0)

<0.001

Cardiogenic shock (n (%))

413(1.7)

291(1.2)

122(11.9)

<0.001

Clinical indices

    

RBC (M/mcl)

4.1(3.5–4.5)

4.1(3.5–4.5)

4.1(3.5–4.6)

0.404

WBC (K/mcl)

10.0(7.1–14.0)

9.8(7.1–13.8)

13.2(9.9–19.0)

0.796

Platelet (K/mcl)

200(157–250)

201(157–250)

197.0(148.0-248.5)

0.110

HB (g/dL)

12.2(10.4–13.6)

12.2(10.5–13.6)

12.1(10.2–13.8)

0.592

Creatinine (mg/dL)

0.97(0.74–1.40)

0.96(0.74–1.38)

1.26(0.88–2.10)

<0.001

BUN (mg/dL)

17.0(12.0–27.0)

17.0(12.0–27.0)

22.0(15.0–34.0)

<0.001

FBG (mmol/L)

129.5(108.0-168.0)

128.5(107.5–166.0)

165.3(133.5–215.0)

<0.001

Triglyceride (mg/dL)

110.0(76.5–165.0)

110.0(76.0-164.0)

114.0(79.2–171.0)

<0.001

Tyg-index

8.90(8.46–9.42)

8.89(8.45–9.41)

9.20(8.72–9.69)

<0.001

TC (mg/dL)

150(120–184)

151(120–185)

136.0(107.4-166.3)

<0.001

HDL (mg/dL)

40.0(31.0-50.5)

40.0(31.0–51.0)

37.0(28.8–47.0)

<0.001

LDL (mg/dL)

82(58–112)

83(58–112)

71.0(47.6–96.9)

<0.001

GCS

Verbal score

Motor score

Eyes score

15(12–15)

5(4–5)

6(6–6)

4(3–4)

15(13–15)

5(4–5)

6(6–6)

4(3–4)

7(3–14)

1(1–4)

4(1–6)

1(1–4)

<0.001

<0.001

<0.001

<0.001

APS

35(24–51)

35(24–50)

79(47–108)

<0.001

APACHE IV

48(34–65)

47(34–64)

91(60–122)

<0.001

Treatment measures

    

Dobutamine (n (%))

146(0.6)

127(0.5)

19(1.9)

<0.001

Dopamine (n (%))

439(1.8)

329(1.4)

110(10.8)

<0.001

Epinephrine (n (%))

151(0.6)

95(0.4)

56(5.5)

<0.001

Norepinephrine (n (%))

1524(6.2)

1211(5.1)

313(30.7)

<0.001

Amiodarone (n (%))

379(1.5)

352(1.5)

27(2.6)

0.003

Statin (n (%))

475(1.9)

460(1.9)

15(1.5)

0.280

  1. CA, cardiac arrest; BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SpO2, saturation of peripheral oxygen; MI, myocardial infarction; AF, atrial fibrillation; CHF, chronic heart failure; CKD, chronic kidney disease; ARF, acute renal failure; RBC, red blood cell; WBC, white blood cell; HB, hemoglobin; BUN, blood urea nitrogen ; FBG, fast blood glucose; TyG index, triglyceride-glucose index; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; GCS, Glasgow Coma Scale; APS, Acute Physiology Score; APACHE IV, Acute Physiology Age Chronic Health Evaluation IV.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840